Literature DB >> 9744369

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11.

.   

Abstract

PURPOSE: To summarize local complications and observations following enucleation of eyes with large choroidal melanoma that were reported prospectively at scheduled examinations of patients enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation.
METHODS: Of 1,003 patients with large choroidal melanoma who were assigned randomly at time of enrollment to enucleation alone or to pre-enucleation radiation, 994 were treated as assigned. Complications and observations were reported to the Coordinating Center on standard forms completed at the time of enucleation surgery and during the immediate 24-hour postsurgery period, 1 to 6 weeks following surgery, 6 and 12 months after enucleation, and at examinations scheduled at 12-month intervals thereafter.
RESULTS: The most common perioperative complication was pain that prolonged hospital stay, which was reported for six patients (1%) who had standard enucleation and eight patients (2%) who had pre-enucleation radiation. Patients treated with pre-enucleation radiation had somewhat more complications reported at the examination 1 to 6 weeks after surgery than did patients treated with enucleation alone, 36 (8%) and 21 (4%), respectively (P = .03, chi2 test), but all complications were minor. During follow-up, fewer biopsy-confirmed tumor recurrences in the orbit were observed among patients treated with pre-enucleation radiation than with enucleation alone (0 vs 5, respectively; P = .03, Fisher exact test). Patients treated with pre-enucleation radiation also had a lower incidence of severe ptosis than did patients treated with enucleation alone (P = .007, log rank test). Among 307 patients examined 5 years after enucleation, the most frequent complication reported at the 5-year examination was poor prosthetic motility for 24 patients (16%) treated with enucleation alone and 30 patients (19%) treated with pre-enucleation radiation.
CONCLUSIONS: Complications were infrequent during the 5-year period following enucleation surgery. Five-year incidence rates and prevalence at the 5-year examination of most complications were similar in the two treatment arms. There was no indication that pre-enucleation radiation had resulted in more serious complications.

Entities:  

Mesh:

Year:  1998        PMID: 9744369     DOI: 10.1016/s0002-9394(98)00091-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Extrascleral extension of a choroidal melanoma after argon photocoagulation and transpupillary thermotherapy.

Authors:  T Tsai; J M O'Brien; R Engstrom; B R Straatsma
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

Review 2.  Lasers for the treatment of intraocular tumors.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2013-05       Impact factor: 3.161

3.  Orbital brachytherapy for extrascleral extension of choroidal melanoma.

Authors:  K L Lin; L B Tena; P T Finger
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

Review 4.  The evolving role of radiation therapy in the management of malignant melanoma.

Authors:  Niloufer Khan; Mohammad K Khan; Alex Almasan; Arun D Singh; Roger Macklis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

5.  Enucleation in malignant choroidal melanoma - results in 15 years of using a new material in the prosthesis of the orbital cavity.

Authors:  C P Tataru; M D Pop
Journal:  J Med Life       Date:  2012-06-18

6.  Cost-effectiveness of proton beam therapy for intraocular melanoma.

Authors:  James P Moriarty; Bijan J Borah; Robert L Foote; Jose S Pulido; Nilay D Shah
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

7.  Visual Loss from Choroidal Melanoma Mimicking Neurological Syndromes.

Authors:  Karim Hammamji; Ehud Reich; Amit Arora; Victoria M L Cohen; Mandeep S Sagoo
Journal:  Case Rep Neurol       Date:  2017-03-20

8.  Small High-Risk Uveal Melanomas Have a Lower Mortality Rate.

Authors:  Rumana N Hussain; Sarah E Coupland; Helen Kalirai; Azzam F G Taktak; Antonio Eleuteri; Bertil E Damato; Carl Groenewald; Heinrich Heimann
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

9.  Patterns of care and survival outcomes after treatment for uveal melanoma in the post-coms era (2004-2013): a surveillance, epidemiology, and end results analysis.

Authors:  Yuan James Rao; Julia Sein; Shahed Badiyan; Julie K Schwarz; Todd DeWees; Perry Grigsby; Prabakar Kumar Rao
Journal:  J Contemp Brachytherapy       Date:  2017-10-20

10.  Mortality after deferral of treatment or no treatment for choroidal melanoma.

Authors:  Bradley R Straatsma; Marie Diener-West; Robert Caldwell; Robert E Engstrom
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.